{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:06:03Z","timestamp":1772136363160,"version":"3.50.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T00:00:00Z","timestamp":1738713600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Previous studies have shown that aspirin is effective as a prophylactic agent against venous thromboembolism (VTE) following proximal femoral fractures (PFF). In Japan, there is a lack of evidence regarding its efficacy and safety in this context. Consequently, aspirin is not covered by insurance for the prevention of venous thrombosis. This study aimed to investigate whether continued aspirin use in patients with PFF, who were already taking aspirin for cerebrovascular disease prevention before injury is effective as a prophylaxis for deep vein thrombosis (DVT). We retrospectively analyzed PFF patients (\u2265\u200965\u00a0years) who underwent postoperative duplex ultrasonography from January 2010 to December 2023.The study compared patients taking aspirin alone (aspirin group) and those not taking antiplatelet agents or anticoagulants (control group), matched by propensity scores. We enrolled 1064 patients while 161 (15%) were in the aspirin group. After matching, 128 patients were analyzed. DVT incidence was not statistically significant between the aspirin (54) and control groups (60) (OR: 0.81; 95%CI: 0.49- 1.36; p\u2009=\u20090.44). Proximal DVT incidence was also similar (OR: 2; 95%CI: 0.50\u20137.00; p\u2009=\u20090.33). Additionally, since use of other postoperative antithrombotic prophylaxis (78%) is thought to have a significant impact on the incidence of DVT, a subgroup analysis was conducted to evaluate the effect of aspirin in patients who did not receive postoperative antithrombotic prophylaxis. Similarly, there was no statistically significant difference in either DVT (OR: 1.38; 95% CI: 0.55\u20133.42; p\u2009=\u20090.49) or proximal DVT (OR: 2.00; 95% CI: 0.37\u201310.92; p\u2009=\u20090.42). This study demonstrates that aspirin is not effective for preventing VTE in patients with PFF in Japan.<\/jats:p>","DOI":"10.1038\/s41598-025-88493-4","type":"journal-article","created":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T02:23:17Z","timestamp":1738722197000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Effectiveness of aspirin in preventing deep vein thrombosis following proximal femoral fracture surgery in Japan"],"prefix":"10.1038","volume":"15","author":[{"given":"Takao","family":"Ohmori","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazukiyo","family":"Toda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takuya","family":"Taoka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takeshi","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Ito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,2,5]]},"reference":[{"key":"88493_CR1","doi-asserted-by":"publisher","first-page":"2089","DOI":"10.2106\/JBJS.15.01329","volume":"98","author":"WC Shin","year":"2016","unstructured":"Shin, W. C. et al. Preoperative prevalence of and risk factors for venous thromboembolism in patients with a hip fracture: An indirect multidetector CT venography study. J. Bone Joint Surg. Am. 98, 2089\u20132095 (2016).","journal-title":"J. Bone Joint Surg. Am."},{"key":"88493_CR2","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1186\/s13018-023-04122-8","volume":"18","author":"T Taoka","year":"2023","unstructured":"Taoka, T. et al. Delayed surgery after hip fracture affects the incidence of venous thromboembolism. J. Orthop. Surg. Res. 18, 630. https:\/\/doi.org\/10.1186\/s13018-023-04122-8 (2023).","journal-title":"J. Orthop. Surg. Res."},{"key":"88493_CR3","doi-asserted-by":"publisher","first-page":"e278S","DOI":"10.1378\/chest.11-2404","volume":"141","author":"YF Ytter","year":"2012","unstructured":"Ytter, Y. F. et al. Prevention of VTE in orthopedic surgery patients: Antithrombotic therapy and prevention of thrombosis, 9th ed: American college of chest physicians evidence-based clinical practice guidelines. Chest. 141, e278S-e325S (2012).","journal-title":"Chest."},{"key":"88493_CR4","doi-asserted-by":"publisher","first-page":"e355","DOI":"10.1097\/BOT.0000000000000387","volume":"29","author":"HC Sagi","year":"2015","unstructured":"Sagi, H. C. et al. Venous thromboembolism prophylaxis in orthopaedic trauma patients: A survey of OTA member practice patterns and OTA expert panel recommendations. J. Orthop. Trauma. 29, e355-362 (2015).","journal-title":"J. Orthop. Trauma."},{"key":"88493_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1097\/EJA.0000000000000728","volume":"35","author":"JY Jenny","year":"2018","unstructured":"Jenny, J. Y., Pabinger, I. & Samama, C. M. European guidelines on perioperative venous thromboembolism prophylaxis: Aspirin. Eur. J. Anaesthesiol. 35, 123\u2013129 (2018).","journal-title":"Eur. J. Anaesthesiol."},{"key":"88493_CR6","doi-asserted-by":"publisher","first-page":"1295","DOI":"10.1016\/S0140-6736(00)02110-3","volume":"355","author":"A Rodgers","year":"2000","unstructured":"Rodgers, A., MacMahon, S., Collins, R. & Prentice, C. Prevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary embolism prevention (PEP) trial. Lancet. 355, 1295\u20131302 (2000).","journal-title":"Lancet."},{"key":"88493_CR7","doi-asserted-by":"publisher","first-page":"603","DOI":"10.2106\/JBJS.21.00168","volume":"104","author":"E Chisari","year":"2022","unstructured":"Chisari, E. et al. Aspirin is an effective prophylaxis for venous thromboembolism in ambulatory patients with femoral neck fracture undergoing hip arthroplasty. J. Bone Joint Surg. Am. 104, 603\u2013609 (2022).","journal-title":"J. Bone Joint Surg. Am."},{"key":"88493_CR8","unstructured":"Japanese orthopaedic association.Guidelines for the Prevention of Symptomatic Venous Thromboembolism. Nankodo Co., Ltd. Tokyo (In Japanese) (2017)."},{"key":"88493_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1177\/003335491513000614","volume":"130","author":"Q Gu","year":"2015","unstructured":"Gu, Q., Dillon, C., Eberhardt, M. S., Wright, J. D. & Burt, V. L. Preventive aspirin and other antiplatelet medication use among U.S. adults aged \u2265 40 years: Data from the national health and nutrition examination survey, 2011\u20132012. Public Health Rep. 130, 643\u2013654 (2015).","journal-title":"Public Health Rep."},{"key":"88493_CR10","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1001\/jamacardio.2022.1988","volume":"7","author":"B Bikdeli","year":"2022","unstructured":"Bikdeli, B. et al. Clinical presentation and short- and long-term outcomes in patients with isolated distal deep vein thrombosis vs proximal deep vein thrombosis in the RIETE registry. JAMA Cardiol. 7, 857\u2013865 (2022).","journal-title":"JAMA Cardiol."},{"key":"88493_CR11","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1302\/0301-620X.43B4.647","volume":"43","author":"RS Garden","year":"1961","unstructured":"Garden, R. S. Low-angle fixation in fractures of the femoral neck. J. Bone Joint Surg. Br. 43, 647\u2013663 (1961).","journal-title":"J. Bone Joint Surg. Br."},{"key":"88493_CR12","doi-asserted-by":"publisher","first-page":"803","DOI":"10.3109\/17453678008990877","volume":"51","author":"JS Jensen","year":"1980","unstructured":"Jensen, J. S. Classification of trochanteric fractures. Acta Orthop. Scand. 51, 803\u2013810 (1980).","journal-title":"Acta Orthop. Scand."},{"key":"88493_CR13","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1080\/00273171.2011.568786","volume":"46","author":"PC Austin","year":"2011","unstructured":"Austin, P. C. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav. Res. 46, 399\u2013424 (2011).","journal-title":"Multivariate Behav. Res."},{"key":"88493_CR14","doi-asserted-by":"publisher","first-page":"2285","DOI":"10.1182\/blood-2006-01-010645","volume":"109","author":"A Undas","year":"2007","unstructured":"Undas, A., Brummel-Ziedins, K. E. & Mann, K. G. Antithrombotic properties of aspirin and resistance to aspirin: beyond strictly antiplatelet actions. Blood. 109, 2285\u20132292 (2007).","journal-title":"Blood."},{"key":"88493_CR15","doi-asserted-by":"publisher","first-page":"1467","DOI":"10.1016\/j.jacc.2004.12.075","volume":"45","author":"JA Chirinos","year":"2005","unstructured":"Chirinos, J. A. et al. Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism. J. Am. Coll. Cardiol. 45, 1467\u20131471 (2005).","journal-title":"J. Am. Coll. Cardiol."},{"key":"88493_CR16","doi-asserted-by":"publisher","first-page":"1776","DOI":"10.1111\/jth.12728","volume":"12","author":"A Undas","year":"2014","unstructured":"Undas, A., Brummel-Ziedins, K. & Mann, K. G. Why does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acid. J. Thromb. Haemost. 12, 1776\u20131787 (2014).","journal-title":"J. Thromb. Haemost."},{"key":"88493_CR17","first-page":"785","volume":"38","author":"M Koupenova","year":"2017","unstructured":"Koupenova, M., Kehrel, B. E., Corkrey, H. A. & Freedman, J. E. Thrombosis and platelets: an update. Eur. Heart J. 38, 785\u2013791 (2017).","journal-title":"Eur. Heart J."},{"key":"88493_CR18","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1182\/hematology.2020000150","volume":"2020","author":"R Diep","year":"2020","unstructured":"Diep, R. & Garcia, D. Does aspirin prevent venous thromboembolism?. Hematol. Am. Soc. Hematol. Educ. Program. 2020, 634\u2013641 (2020).","journal-title":"Hematol. Am. Soc. Hematol. Educ. Program."},{"key":"88493_CR19","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1712746","volume":"378","author":"DR Anderson","year":"2018","unstructured":"Anderson, D. R. et al. Aspirin or rivaroxaban for VTE prophylaxis after hip or knee arthroplasty. N. Engl. J. Med. 378, 699\u2013707 (2018).","journal-title":"N. Engl. J. Med."},{"key":"88493_CR20","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1001\/jama.2022.13416","volume":"328","author":"VS Sidhu","year":"2022","unstructured":"Sidhu, V. S. et al. Effect of aspirin vs enoxaparin on symptomatic venous thromboembolism in patients undergoing hip or knee arthroplasty: The CRISTAL randomized trial. JAMA. 328, 719\u2013727 (2022).","journal-title":"JAMA."},{"key":"88493_CR21","doi-asserted-by":"publisher","first-page":"e0235628","DOI":"10.1371\/journal.pone.0235628","volume":"15","author":"BE Haac","year":"2020","unstructured":"Haac, B. E. et al. Aspirin versus low-molecular-weight heparin for venous thromboembolism prophylaxis in orthopaedic trauma patients: A patient-centered randomized controlled trial. PLoS One. 15, e0235628. https:\/\/doi.org\/10.1371\/journal.pone.0235628 (2020).","journal-title":"PLoS One."},{"key":"88493_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1056\/NEJMoa2205973","volume":"388","author":"RV O'Toole","year":"2023","unstructured":"O\u2019Toole, R. V. et al. Aspirin or low-molecular-weight heparin for thromboprophylaxis after a fracture. N. Engl. J. Med. 388, 203\u2013213 (2023).","journal-title":"N. Engl. J. Med."},{"key":"88493_CR23","doi-asserted-by":"publisher","first-page":"111078","DOI":"10.1016\/j.injury.2023.111078","volume":"54","author":"S Peng","year":"2023","unstructured":"Peng, S., Zhang, M., Jin, J. & MacCormick, A. D. The effectiveness of venous thromboembolism prophylaxis interventions in trauma patients: A systematic review and network meta-analysis. Injury. 54, 111078. https:\/\/doi.org\/10.1016\/j.injury.2023.111078 (2023).","journal-title":"Injury."},{"key":"88493_CR24","doi-asserted-by":"publisher","first-page":"102606","DOI":"10.1016\/j.otsr.2020.04.002","volume":"107","author":"JE Farey","year":"2021","unstructured":"Farey, J. E., An, V. V. G., Sidhu, V., Karunaratne, S. & Harris, I. A. Aspirin versus enoxaparin for the initial prevention of venous thromboembolism following elective arthroplasty of the hip or knee: A systematic review and meta-analysis. Orthop. Traumatol. Surg. Res. 107, 102606. https:\/\/doi.org\/10.1016\/j.otsr.2020.04.002 (2021).","journal-title":"Orthop. Traumatol. Surg. Res."},{"key":"88493_CR25","doi-asserted-by":"publisher","first-page":"e933","DOI":"10.1097\/HS9.0000000000000933","volume":"7","author":"REG Schutgens","year":"2023","unstructured":"Schutgens, R. E. G. & Middeldorp, S. Aspirin as thromboprophylaxis in orthopedic surgery: A matter of perspective. Hemasphere. 7, e933. https:\/\/doi.org\/10.1097\/HS9.0000000000000933 (2023).","journal-title":"Hemasphere."},{"key":"88493_CR26","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1007\/s00264-021-04941-6","volume":"45","author":"T Ohmori","year":"2021","unstructured":"Ohmori, T. et al. Retrospective high volume comparative study suggests that patients on aspirin could have immediate surgery for hip fractures without significant blood loss. Int. Orthop. 45, 543\u2013549 (2021).","journal-title":"Int. Orthop."},{"key":"88493_CR27","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1097\/CORR.0000000000000613","volume":"477","author":"M Faour","year":"2019","unstructured":"Faour, M. et al. No Difference between low- and regular-dose aspirin for venous thromboembolism prophylaxis after THA. Clin. Orthop. Relat. Res. 477, 396\u2013402 (2019).","journal-title":"Clin. Orthop. Relat. Res."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88493-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88493-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T02:23:21Z","timestamp":1738722201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-88493-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,5]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["88493"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-88493-4","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4544364\/v1","asserted-by":"object"}]},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,5]]},"assertion":[{"value":"7 June 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 January 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 February 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"4325"}}